Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer
暂无分享,去创建一个
M. Fakih | B. Barber | C. Graham | L. Schwartzberg | G. Hechmati | J. Hjelmgren | H. Knox | G. Maglinte